| Aspen Pharma Schweiz GmbH - Ovestin Ovula, Vaginalovula | | 47183 | | 01 | | Ovestin Ovula | | Vaginalovula | | G03CA04 | | Estriol | | 31.08.1987 | | |
| | Composition | | estriolum 0.5 mg, adeps solidus, glyceroli monoricinoleas, macrogoli aether cetostearylicus, E 321 0.03 mg, E 304, acidum citricum, propylenglycolum, pro ovulo. | | Packungsbestandteile | | Vaginal ovules | | | | | Active Agent | Dose |
|---|
| Estriol | 0.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Estriol | 0.5 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid | | | Adeps Solidus | | | E 304 | | | E 321 | 0.03 mg | | Glyceroli Monoricinoleas | | | Macrogoli Aether Cetostearylicus | | | Pro Ovulo | | | Propylenglycol | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | 15 suppositories | 4.79 | 14.45 | B | SL | No |
|
|
